Investor Presentation Financial Highlights slide image

Investor Presentation Financial Highlights

Tüpraş and Med Refining Margins Tüpraş Net Margin Med Margin 28.2 ($/bbl) Gross Inventory Margin Effect Clean Clean Gross NET Margin Margin Net Med Processed Margin Margin* bbl (mn) 9M 2023 21.1 1.1 20.0 12.2 13.3 28.7 137.6 16.5 12M 2022 23.9 0.7 23.2 15.8 16.5 28.2 198.8 9M 2022 21.2 0.9 20.3 14.0 14.9 28.0 153.3 5.7 3.7 1.7 1.3 -0.2 2019 2020 2021 1.6 12M 2021 10.5 2.1 8.4 3.6 5.7 1.6 190.2 2022 Operational advantages supporting the Tüpraş Refinery Margin compared to the benchmark Mediterranean Peers: . Ability to use heavier and sour crudes with higher complexity • Access to a wide range of cheaper sources of crude oil • Close proximity to major suppliers reduces transport costs . Lower cost basis and more efficient energy usage * Weight of Ural crude oil is 100% for crude oil supplies in the theoretical calculation of Med Margin. Dec-23 Investor Presentation Financials Ability to produce a broad range of refined products with higher value added Direct pipeline connections with domestic clients www.tupras.com.tr 27
View entire presentation